Loading clinical trials...
Loading clinical trials...
A Multicenter, Double-blinded, Randomized, Placebo-controlled Trial to Compare the Effectiveness of Intratympanic Injections methylPREDnisolon Versus Placebo in the Treatment of Vertigo Attacks in MENière's Disease (PREDMEN Trial).
Conditions
Interventions
Methylprednisolon
Placebo
Locations
1
Netherlands
Leiden University Medical Centre
Leiden, South Holland, Netherlands
Start Date
October 1, 2023
Primary Completion Date
May 1, 2026
Completion Date
February 1, 2027
Last Updated
December 4, 2023
NCT03795675
NCT05424302
NCT04218123
NCT05582148
NCT04935970
NCT02529475
Lead Sponsor
Leiden University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions